European Journal of Clinical Pharmacology

, Volume 30, Issue 4, pp 463–466 | Cite as

Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine

  • Th. Zysset
  • E. Peretti


The influence of concomitant administration of isoniazid (INH) on the acetylation of sulphadimidine has been studied in 6 healthy volunteers, previously identified as having the fast acetylator phenotype. INH was administered in a slow release form (500 mg tablet) 1 hour before the sulphadimidine. Acetylation of sulphadimidine was measured in plasma 6 h after its intake and in urine collected between 5 and 6 hours. INH significantly decreased the acetylated fraction of sulphadimidine in plasma from 69.0 to 54.0 and in urine from 85.9 to 81.2%. This was reflected in a significantly higher plasma concentration of unconjugated sulphadimidine and reduced urinary excretion of acetylated sulphadimidine. It is concluded that concomitant administration of INH inhibits acetylation of sulphadimidine. Fast acetylators at the border line of discrimination, may be misclassified if phenotyped with sulphadimidine during concomitant administration of INH.

Key words

sulphadamine isozianid interaction acetylator phenotyping 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Evans DAP, Manley KA, McKumick VA (1960) Genetic control of isoniazid metabolism in man. Br Med J 2: 485–491Google Scholar
  2. 2.
    Clark DWJ (1985) Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 29: 342–375Google Scholar
  3. 3.
    Dubbels R, Kattner E, Sell-Maurer D, Schloot W (1980) Sulfadimidine and isoniazid loading in man and laboratory rats. Arzneimittelforsch/Drug Res 30 (II): 1574–1579Google Scholar
  4. 4.
    Evans DAP (1969) An improved and simplified method of detecting the acetylator phenotype. J Med Genet 6: 405–407Google Scholar
  5. 5.
    Bratton AC, Marshall EK Jr (1939) A new coupling component for sulphanilamide determination. J Biol Chem 128: 537Google Scholar
  6. 6.
    Timbrell JA, Wright JM, Smith CM (1977) Determination of hydrazine metabolites of isoniazid in human urine by gas chromatography. J Chromatogr 138: 165–172Google Scholar
  7. 7.
    Du Souich P, McLean AJ, Stoeckel K, Ohlendorf D, Gibaldi M (1979) Screening methods using sulfamethazine for determining acetylator phenotype. Clin Pharmacol Ther 26: 757–765Google Scholar
  8. 8.
    Talseth T, Landmark KH (1977) Polymorphic acetylation of sulphadimidine in normal and uraemic man. Eur J Clin Pharmacol 11: 33–36Google Scholar
  9. 9.
    Du Souich P, Lalka D, Slaughter R, Elvin AT, McLean AJ (1979) Mechanisms of nonlinear disposition kinetics of sulfamethazine. Clin Pharmacol Ther 25: 172–183Google Scholar
  10. 10.
    Platzer R, Küpfer A, Bircher J, Preisig R (1978) Polymorphic acetylation and aminopyrine demthylation in Gilbert's syndrome. Eur J Clin Invest 8: 219–223Google Scholar
  11. 11.
    Glatthaar E, Gärtig D, Stander MF, Kleeberg HH (1977) Isoniazid levels in black patients dosed with a matrix preparation (tebesium). Prax Pneumol 31: 885–889Google Scholar
  12. 12.
    Ylitalo P, Auterinen L, Marttinen A, Koivula T (1984) Acetylator phenotyping with sulphadimidine in patients receiving isoniazid. Int J Clin Pharmacol Res IV: 141–144Google Scholar
  13. 13.
    Gilman AG, Goodman LS, Gilman A (ed) (1980) The pharmacological basis of therapeutics, 6th ed. Macmillan, New York Toronto LondonGoogle Scholar
  14. 14.
    Tiitinen H (1969) Isoniazid and ethionamide serum levels and inactivation in Finnish subjects. Scand J Respir Dis 50: 110–124Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • Th. Zysset
    • 1
  • E. Peretti
    • 1
  1. 1.Department of Clinical PharmacologyUniversity of BerneBerneSwitzerland

Personalised recommendations